U.S. House · 117th Congress · H.R. 2148
Prescription Drug Price Relief Act of 2021
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ro KhannaD-CA-17
- Introduced
- March 23, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (18)
18 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Jamaal BowmanD-NY-16
- Peter A. DeFazioD-OR-4
- Rosa L. DeLauroD-CT-3
- Pramila JayapalD-WA-7
- Mondaire JonesD-NY-17
- Barbara LeeD-CA-13
- Joe NeguseD-CO-2
- Eleanor Holmes NortonD-DC-AL
- Alexandria Ocasio-CortezD-NY-14
- Ilhan OmarD-MN-5
- Mark PocanD-WI-2
- Ayanna PressleyD-MA-7
- Jamie RaskinD-MD-8
- Janice D. SchakowskyD-IL-9
- Rashida TlaibD-MI-13
- Peter WelchD-VT-AL
Signed on later
- Cori BushD-MO-1March 26, 2021
- Mark DeSaulnierD-CA-11March 26, 2021